Subject: HLTY Signs Lucrative and Exclusive Distribution Agreement

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
HLTY Signs Lucrative and Exclusive Distribution Agreement
Hot Stock to WatchHot Stock to Watch

Company: PreCheck Health Services, Inc. (Pink Sheets: HLTY)


Price: 1.04

Change (%): + 0.03 (2.97)

Volume: 2,851
HLTY Chart

PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device

MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) — PreCheck Health Services, Inc. (OTC:HLTY) is a Florida corporation that has entered into an exclusive distribution agreement for the new PreCheck Health Services “PC8B” medical device for sale coast to coast in the United States.

The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology.

This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a one-page comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action. The capabilities of the PC8B gives physicians the opportunity for early diagnosis and the ability to prevent many chronic conditions and diseases.

“By entering into this exclusive agreement we now can provide doctors with one of the best screening devices in the United States. Under the Affordable Care Act, physicians are being asked to provide more preventive care than previously required. Insurance companies as well as Medicare and Medicaid have learned that preventive care will reduce their cost of insuring patients. If chronic diseases are detected early, not only are we saving patients from the onset of chronic disease, the insurer and patient will save tens of thousands of dollars for care over the life of the patient,” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks